seed
Stage
1
Investors
About
Ingenix develops a multimodal, multiscale generative AI platform that simulates clinical drug trials to accurately predict clinical endpoints and adverse events from molecular to population levels.
Explore Ingenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.